Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

IDEAYA Biosciences, Inc. IDYA

Full chart Compare
Set alert

Price alert · IDYA

All alert types
31.24 USD +0.59 (+1.92%)

At closeNov 6, 2026, 4:00 PM EST

31.24 0.00 0.00%

After hours · Nov 6, 4:00 PM ET

30.45 Day range 31.33
27.60 52-week range 42.48
YTD
-9.63%
1 year
+4.66%

Financial health

Altman Z-Score

12.95 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 2

Valuation

P/E -27.0×
FY 2017: -13.5×FY 2018: -4.6×FY 2019: -3.9×FY 2020: -10.7×FY 2021: -16.8×FY 2022: -12.8×FY 2023: -18.2×FY 2024: -7.6×FY 2025: -27.0×
FY 2017 5y median -16.8× FY 2025
P/S 14.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 17.7×FY 2021: 29.8×FY 2022: 14.8×FY 2023: 87.5×FY 2024: 300×FY 2025: 14.0×
FY 2017 5y median 29.8× FY 2025
P/B 3.0×
FY 2017: -10.1×FY 2018: -3.3×FY 2019: 1.5×FY 2020: 1.7×FY 2021: 2.8×FY 2022: 2.2×FY 2023: 3.3×FY 2024: 2.0×FY 2025: 3.0×
FY 2017 5y median 2.8× FY 2025
P/FCF -41.6×
FY 2017: -11.4×FY 2018: -5.4×FY 2019: -3.7×FY 2020: 6.3×FY 2021: -14.3×FY 2022: -8.3×FY 2023: -17.4×FY 2024: -8.3×FY 2025: -41.6×
FY 2017 5y median -14.3× FY 2025
EV/EBITDA -19.2×
FY 2017: -13.7×FY 2018: -4.1×FY 2019: -3.1×FY 2020: -8.5×FY 2021: -15.5×FY 2022: -12.2×FY 2023: -17.4×FY 2024: -7.5×FY 2025: -19.2×
FY 2017 5y median -15.5× FY 2025
EV/Sales 13.6×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 14.4×FY 2021: 26.7×FY 2022: 13.5×FY 2023: 80.9×FY 2024: 291×FY 2025: 13.6×
FY 2017 5y median 26.7× FY 2025
FCF Yield -2.4%
FY 2017: -8.8%FY 2018: -18.4%FY 2019: -26.8%FY 2020: 15.9%FY 2021: -7.0%FY 2022: -12.0%FY 2023: -5.7%FY 2024: -12.0%FY 2025: -2.4%
FY 2017 5y median -7.0% FY 2025

Profitability

Gross Margin -43.9%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 92.9%FY 2021: 93.8%FY 2022: 95.9%FY 2023: 82.9%FY 2024: 45.2%FY 2025: -43.9%
FY 2017 5y median 82.9% FY 2025
Operating Margin -72.8%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -180.9%FY 2021: -179.9%FY 2022: -122.7%FY 2023: -574.9%FY 2024: -4671.1%FY 2025: -72.8%
FY 2017 5y median -179.9% FY 2025
Net Margin -52.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -176.6%FY 2021: -178.1%FY 2022: -115.2%FY 2023: -483.0%FY 2024: -3921.1%FY 2025: -52.0%
FY 2017 5y median -178.1% FY 2025
ROE -11.1%
FY 2017: 75.4%FY 2018: 70.2%FY 2019: -41.8%FY 2020: -17.4%FY 2021: -16.5%FY 2022: -16.8%FY 2023: -18.2%FY 2024: -25.9%FY 2025: -11.1%
FY 2017 5y median -16.8% FY 2025
ROIC -15.2%
FY 2017: -96.0%FY 2018: -40.0%FY 2019: -41.3%FY 2020: -13.5%FY 2021: -14.9%FY 2022: -17.5%FY 2023: -21.5%FY 2024: -30.3%FY 2025: -15.2%
FY 2017 5y median -17.5% FY 2025
ROA -10.2%
FY 2017: -67.9%FY 2018: -35.6%FY 2019: -37.1%FY 2020: -11.6%FY 2021: -13.0%FY 2022: -15.1%FY 2023: -17.4%FY 2024: -24.4%FY 2025: -10.2%
FY 2017 5y median -15.1% FY 2025

Growth (YoY)

Revenue 3024.4%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 43.0%FY 2022: 82.3%FY 2023: -54.1%FY 2024: -70.1%FY 2025: 3024.4%
FY 2017 FY 2025
Operating Income 51.3%
FY 2017: 0.0%FY 2018: -152.2%FY 2019: -21.6%FY 2020: 20.2%FY 2021: -42.2%FY 2022: -24.3%FY 2023: -115.1%FY 2024: -143.2%FY 2025: 51.3%
FY 2017 FY 2025
EPS (diluted) 61.9%
FY 2017: 0.0%FY 2018: -190.4%FY 2019: 21.2%FY 2020: 31.1%FY 2021: -7.6%FY 2022: -0.7%FY 2023: -38.0%FY 2024: -71.4%FY 2025: 61.9%
FY 2017 FY 2025
Free Cash Flow 70.8%
FY 2017: 0.0%FY 2018: -109.8%FY 2019: -38.7%FY 2020: 235.2%FY 2021: -206.3%FY 2022: -55.1%FY 2023: -29.8%FY 2024: -113.8%FY 2025: 70.8%
FY 2017 FY 2025

Financial Health

Current Ratio 11.3×
FY 2017: 5.6×FY 2018: 16.7×FY 2019: 14.6×FY 2020: 7.5×FY 2021: 5.6×FY 2022: 11.7×FY 2023: 19.7×FY 2024: 15.0×FY 2025: 11.3×
FY 2017 5y median 11.7× FY 2025
Quick Ratio 11.3×
FY 2017: 5.6×FY 2018: 16.7×FY 2019: 14.6×FY 2020: 7.5×FY 2021: 5.6×FY 2022: 11.7×FY 2023: 19.7×FY 2024: 15.0×FY 2025: 11.3×
FY 2017 5y median 11.7× FY 2025
Debt / Equity 0.0×
FY 2017: -0.2×FY 2018: 0.0×FY 2019: 0.1×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025
Net Debt / EBITDA 0.5×
FY 2017: 0.2×FY 2018: 0.6×FY 2019: 0.7×FY 2020: 2.0×FY 2021: 1.8×FY 2022: 1.2×FY 2023: 1.4×FY 2024: 0.2×FY 2025: 0.5×
FY 2017 5y median 1.2× FY 2025
Interest Coverage 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31